Cas:945034-41-3 Ethyl 5-amino-4-hydroxy-2-naphthoate manufacturer & supplier

We serve Chemical Name:Ethyl 5-amino-4-hydroxy-2-naphthoate CAS:945034-41-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 5-amino-4-hydroxy-2-naphthoate

Chemical Name:Ethyl 5-amino-4-hydroxy-2-naphthoate
CAS.NO:945034-41-3
Synonyms:Ethyl 5-amino-4-hydroxy-2-naphthoate
Molecular Formula:C13H13NO3
Molecular Weight:231.24700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:72.55000
Exact Mass:231.09000
LogP:2.88550

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 5-amino-4-hydroxy-2-naphthoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 5-amino-4-hydroxy-2-naphthoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 5-amino-4-hydroxy-2-naphthoate Use and application,Ethyl 5-amino-4-hydroxy-2-naphthoate technical grade,usp/ep/jp grade.


Related News: At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Ethyl 5-amino-4-hydroxy-2-naphthoate manufacturer At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Ethyl 5-amino-4-hydroxy-2-naphthoate supplier At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Ethyl 5-amino-4-hydroxy-2-naphthoate vendor The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. Ethyl 5-amino-4-hydroxy-2-naphthoate factory Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov.